Weight Loss (Obesity): The SURMOUNT-1 trial, which studied non-diabetic obese or overweight adults, showed staggering results over 72 weeks
Tirzepatide's dual GIP and GLP-1 receptor activation typically produces stronger appetite suppression than semaglutide's GLP-1-only mechanism
Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K et al
And while I didnt have one of those overnight, everything is fixed experiences (which is virtually impossible anyway, TBH), I did notice a few shifts that felt meaningful: my mood was a little more even, I slept a bit better, and the bloating Id been dealing with eased up in a noticeable way
Pick up your Mounjaro prescription, if prescribed